Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)

Recruiting N/A Interventional Study
Critical Illness Pediatric Intensive Care Enteral Nutrition Therapy Dietary Protein
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 11
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
96 (estimated)
Sponsor
University of British Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this intervention study is to evaluate the difference in nutrition status markers (weight and muscle mass) when giving dietary protein by continuous or bolus delivery in critically ill children ages 1-11y. The main questions it aims to answer are: Primary: Bolus protein delivery will lessen the decline in mid-upper arm circumference (MUAC) z-score by 0.5 standard deviation in critica…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Children admitted to PICU over 1 year of age and younger than 11 years of life * Expected to remain in the pediatric intensive care unit for longer than 72 hours * Receiving standard pediatric formula via NGT/OGT/GT Exclusion Criteria: * Neuromuscular condition such as muscu…
Contacts

Kaitlin A Berris, BSc

604-875-2000

kaitlin.berris@bcchr.ca

CONTACT

Rajavel Elango, PhD

604-875-2000

relango@bcchr.ubc.ca

CONTACT